Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute of Rheumatology

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Institute of Rheumatology, Belgrade (Institute of Rheumatology Belgrade) is a specialized tertiary-care center dedicated to the diagnosis, treatment, and research of rheumatic and musculoskeletal diseases, with strong relevance for clinical research in immunology and chronic inflammatory conditions. The institute integrates clinical services with academic and scientific activities, functioning as a teaching and research base in collaboration with medical education institutions in Serbia. It provides comprehensive care across internal medicine, rheumatology, physical medicine and rehabilitation, and advanced diagnostics such as radiology, ultrasound, osteodensitometry, and laboratory services, enabling a multidisciplinary approach to patient management.

Source: Trial-derived.
46Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
16Active Trials
Source: Trial-derived.
24Completed Trials
Source: Trial-derived.
34Unique Conditions
Source: Trial-derived.
25Unique Sponsors

Conditions

Source: Trial-derived. Rheumatoid Arthritis (9)Source: Trial-derived. Systemic Lupus Erythematosus (7)Source: Trial-derived. Lupus Erythematosus, Systemic (5)Source: Trial-derived. Psoriatic Arthritis (3)Source: Trial-derived. Active Idiopathic Inflammatory Myopathy (2)Source: Trial-derived. Antisynthetase Syndrome (2)Source: Trial-derived. Dermatomyositis (2)Source: Trial-derived. Diffuse Cutaneous Systemic Sclerosis (2)

Sponsors

Source: Trial-derived. Amgen (8)Source: Trial-derived. AbbVie (6)Source: Trial-derived. Pfizer (6)Source: Trial-derived. argenx (4)Source: Trial-derived. Biogen (3)Source: Trial-derived. Eli Lilly and Company (3)Source: Trial-derived. Genentech, Inc. (2)Source: Trial-derived. Incyte Corporation (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. X-Ray
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Actigraphy (accelerometer) activity monitoring
Source: AI-inferred. Unstimulated salivary flow measurement (sialometry)